Management of pain in the older person with cancer. Part 2: Treatment options

ONCOLOGY

Volumn 22, Issue 2, 2008, Pages 148-152

  Delgado Guay, Marvin Omar ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BUPRENORPHINE; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; GABAPENTIN; HYDROMORPHONE; LIDOCAINE; METHADONE; METHYLPHENIDATE; METOCLOPRAMIDE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PETHIDINE; PROTON PUMP INHIBITOR; TRAMADOL; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

ADJUVANT THERAPY; AGING; ALLODYNIA; ANALGESIA; ANESTHESIA; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; COGNITIVE DEFECT; CONSTIPATION; DELIRIUM; DIGESTIVE SYSTEM ULCER; DISABILITY; DISEASE EXACERBATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; ELDERLY CARE; EMOTIONAL STRESS; GASTROINTESTINAL HEMORRHAGE; HALLUCINATION; HUMAN; HYPERALGESIA; LIVER DISEASE; MYOCLONUS; NAUSEA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROPATHIC PAIN; NEUROSURGERY; NEUROTOXICITY; NONHUMAN; PAIN ASSESSMENT; PRURITUS; PSYCHOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; REHABILITATION MEDICINE; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; STOMACH ULCER; THROMBOCYTE AGGREGATION INHIBITION; URINE RETENTION; AGE; AGED; FEMALE; MALE; NEOPLASM; PAIN;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS; ANALGESICS, OPIOID; BUPRENORPHINE; FEMALE; FENTANYL; HUMANS; MALE; NEOPLASMS; PAIN;

EID: 44949161169     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Zech DFJ, Grond S, Lynch J, et al: Validation of the World Health Organization guidelines for cancer pain relief: A 10-year prospective study. Pain 63:65-76, 1995.
2. Yennurajalingam S, Braiteh F, Bruera E: Pain and terminal delirium research in the elderly. Clin Geriatr Med 21:93-119, 2005.
3. Mercadante S, Arcuri E: Pharmacological management of cancer pain in the elderly. Drugs Aging 24:761-776, 2007.
4. Goldstein N, Morrison S: Treatment of pain in older patients. Crit Rev Oncol Hematol 54:157-164, 2005.
5. Balducci L: Management of cancer pain in geriatric patients. J Support Oncol 1:175-191, 2003.
6. Fine P: Pharmacological management of persistent pain in older patients. Clin J Pain 20:220-226, 2004.
7. Viganó A, Bruera E, Suarez-Almazor ME: Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 83:1244-1250, 1998.
8. Grudt TJ, Williams JT: Opioid receptors and the regulation of ion conductances. Rev Neurosci 6:279-286, 1995.
9. Lipman AG, Gautier GM: Pharmacology of opioid drugs: Basic principles, in Portenoy RK, Bruera E (eds): Topics in Palliative Care, vol 1, pp 137-161. New York, Oxford University Press, 1997.
10. Pasternak GW: The pharmacology of mu analgesics: From patients to genes. Neuroscientist 7:220-231, 2001.
11. Murray A, Hagen N: Hydromorphone. J Pain Symptom Manage 29:S57-S66, 2005.
12. Zheng M, McErlane KM, Ong MC: Hydromorphone metabolites: Isolation and identification from pooled urine samples of a cancer patient. Xenobiotica 32:427-439, 2002.
13. Walsh D: Advances in opioid therapy and formulations. Support Care Cancer 13:138-144, 2005.
14. Bruera E, Rico MA, Bertolino M, et al: A prospective open study of oral methadone in the treatment of cancer pain, in Devor M, Rowbotham MC, Weisenfield-Hallin Z (eds): Proceedings of the Ninth World Congress of Pain, pp 957-963. Seattle, IASP Press, 2000.
15. Ripamonti C, Bianchi M: The use of methadone for cancer pain. Hematol Oncol Clin North Am 16:543-544, 2002.
16. Murtagh F, Chai MO, Donohoe P, et al: The use of opioid analgesia in end-stage renal disease patients managed without dialysis: Recommendations for practice. J Pain Palliat Care Pharmacother 21:5-16, 2007.
17. Kreek MI, Schechter AJ, Gutjahr CL, et al: Methadone use in patients with chronic renal disease. Drug Alcohol Depend 5:197-205, 1980.
18. Böer RH: Renal impairment: A challenge for opioid treatment? The role of buprenorphine. Palliat Med 20:s17-s23, 2006.
19. Donnelly S, Davis MP, Walsh D, et al: Morphine in cancer pain management: A practical guide. Support Care Cancer 10:13-35, 2002.
20. Pauwels R, Buist A, Calcerley P, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): Executive summary. Respir Care 46:798-825, 2001.
21. Bourke D, Warley A: The steady state and breathing methods compared during morphine administration in humans. J Physiol 419:509-517, 1989.
22. Clemens K, Klaschik E: Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage 33:473-481, 2007.
23. Estfan B, Mahmoud F, Shaheen P, et al: Respiratory function during parenteral opioid titration for cancer pain. Palliat Med 21:81-86, 2007.
24. Sinclair S, Raffin S, Pereira J, et al: Collective soul: The spirituality of an interdisciplinary palliative care team. Palliat Support Care 4:13-24, 2006.